Orica-GreenEdge still hope to have Simon Yates at Tour de France despite delay in doping case

Simon Yates and Orica-GreenEdge have yet to hear from the UCI about a sanction for failing a drugs test but the team hopes he will be available for the Tour de France

Simon Yates on stage eight of the 2014 Tour de France

(Image credit: Graham Watson)

Orica-GreenEdge hold out hope for Simon Yates, saying he could still race the Tour de France on July 2 if the UCI decides on his Terbutaline case in time.

The 23-year-old Englishman used asthma drug Terbutaline without permission during the Paris-Nice stage race in March. Australian WorldTour team Orica-GreenEdge confirmed that they had made an error in not applying for a therapeutic use exemption (TUE). With a TUE, a rider may freely use the substance.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Gregor Brown

Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.